---
title: HR 1904. National Ovarian Cancer Awareness Day at the state capitol; September 16, 2026; recognize
collection: bills
id: 2025-2026/hr1904
cite_as: HR 1904, 2025-2026 Regular Session (Ga.)
canonical_url: https://georgiacommons.org/bills/2025-2026/hr1904
md_url: https://georgiacommons.org/bills/2025-2026/hr1904.md
text_url: https://georgiacommons.org/bills/2025-2026/hr1904/text
source_url: https://www.legis.ga.gov/legislation/74452
date: 2026-03-25
status: passed
corpus_version: bills-2026-09-13
license: Public record of the Georgia General Assembly, via LegiScan; see about.md
publisher: Georgia Commons, an independent project of Georgia Civic Data. Not the State of Georgia. Not legal advice.
up: https://georgiacommons.org/bills/2025-2026.md
previous: https://georgiacommons.org/bills/2025-2026/hr1903.md
next: https://georgiacommons.org/bills/2025-2026/hr1905.md
index: https://georgiacommons.org/bills/index.md
omitted: votes and history
omitted_chars: 134
omitted_url: https://georgiacommons.org/bills/2025-2026/hr1904.md?full=1
bill_number: HR 1904
session: 2025-2026 Regular Session
session_slug: 2025-2026
chamber: House
bill_type: resolution
status_date: 2026-03-25
last_action: House Read and Adopted
sponsors:
  - Lisa Campbell
text_version: Introduced
has_text: true
legiscan_url: https://legiscan.com/GA/bill/HR1904/2025
upstream_id: 2138467
summaries_model: claude-sonnet-5
topic_tags:
  - ovarian cancer awareness
  - women's health
  - cancer research
  - health disparities
---

# HR 1904. National Ovarian Cancer Awareness Day at the state capitol; September 16, 2026; recognize

## Text

House Resolution 1904
By: Representative Campbell of the 35th
A RESOLUTION
Recognizing September 16, 2026, as National Ovarian Cancer Awareness Day at the state
capitol; and for other purposes.
WHEREAS, ovarian cancer is the fifth-leading cause of cancer deaths of women in the
United States and causes more deaths than any other gynecologic cancer; and
WHEREAS, in the United States, a woman's lifetime risk of being diagnosed with ovarian
cancer is about one in 91; and
WHEREAS, the American Cancer Society estimates 20,890 cases of ovarian cancer will be
newly diagnosed in 2026, and 12,730 individuals will die from the disease nationwide; and
WHEREAS, the five-year survival rate for ovarian cancer is 51.6 percent, and survival rates
vary greatly depending on the stage of diagnosis; and
WHEREAS, the five-year survival rate for ovarian cancer is over 90 percent for individuals
diagnosed in early stages; and
WHEREAS, while the mammogram can detect breast cancer and the pap smear can detect
cervical cancer, there is no reliable early detection test for ovarian cancer; and
WHEREAS, in June 2007, the first national consensus statement on ovarian cancer
symptoms was developed to provide consistency in describing symptoms to make it easier
for women to learn and remember those symptoms; and
WHEREAS, Black women with ovarian cancer are more likely to have late-stage diagnoses,
receive lower quality clinical services, and have lower five-year survival rates than
non-Black women; and
WHEREAS, Black women have a five-year ovarian cancer mortality rate of 62 percent,
while the five-year ovarian cancer mortality rate is 54 percent for White women; and
WHEREAS, women of color, low-income women, and women living in rural areas have
more barriers to accessing a standard quality of care and are more likely to receive care at
a facility that has poorer adherence to National Comprehensive Cancer Network treatment
guidelines; and
WHEREAS, the proportion of ovarian cancer cases in women serving on active duty who
are less than 45 years of age is substantially greater than in the general population; and
WHEREAS, too many people remain unaware that the symptoms of ovarian cancer often
include bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly, urinary
symptoms, and several other vague symptoms that are often easily confused with other
diseases; and
WHEREAS, improved awareness of the symptoms of ovarian cancer by the public and health
care providers can lead to quicker diagnoses and more treatment opportunities; and
WHEREAS, the lack of an early detection test for ovarian cancer combined with its vague
symptoms mean that approximately 80 percent of cases of ovarian cancer are detected at an
advanced stage; and
WHEREAS, issues collecting and reporting data on treatment and outcomes related to
ovarian cancer risk, especially for underserved communities and marginalized populations,
can impede the development of effective policy; and
WHEREAS, all women are at risk for ovarian cancer, but approximately 20 percent of
women who are diagnosed with ovarian cancer have a hereditary predisposition to ovarian
cancer, which places them at even higher risk; and
WHEREAS, scientists and physicians have uncovered changes in the BRCA genes that some
women inherit from their parents, which may make those women 30 times more likely to
develop ovarian cancer; and
WHEREAS, the family history of a woman has been found to play an important role in
accurately assessing her risk of developing ovarian cancer, and medical experts believe that
family history should be taken into consideration during the annual well-woman visit of any
woman; and
WHEREAS, those women who have a family history of ovarian or breast cancer should
consider genetic testing and counseling to determine whether their risk of developing a
heritable cancer is elevated; and
WHEREAS, women who know that they are at high risk of ovarian cancer may undertake
prophylactic measures like an opportunistic salpingectomy to help reduce the risk of
developing this disease; and
WHEREAS, guidelines issued by the National Comprehensive Cancer Network and the
Society of Gynecologic Oncology recommend that all individuals diagnosed with ovarian
cancer receive genetic counseling and genetic testing regardless of their family history; and
WHEREAS, studies consistently show that compliance with these guidelines is alarmingly
low, with recently published National Cancer Institute-funded research finding that in 2013
and 2014, only one-third of ovarian cancer survivors have undergone such testing; and
WHEREAS, according to a 2016 consensus report by the National Academy of Medicine,
"there remain surprising gaps in the fundamental knowledge about and understanding of
ovarian cancer" across all aspects of the disease; and
WHEREAS, ovarian cancer research remains underfunded relative to its mortality rate,
making increased federal investment critical to progress; and
WHEREAS, ongoing investments in ovarian cancer research and education and awareness
efforts are critical to closing these gaps and improving survivorship for women with ovarian
cancer.
NOW, THEREFORE, BE IT RESOLVED BY THE HOUSE OF REPRESENTATIVES that
the members of this body recognize September 16, 2026, as National Ovarian Cancer
Awareness Day at the state capitol.
BE IT FURTHER RESOLVED that the Clerk of the House of Representatives is authorized
and directed to make appropriate copies of this resolution available for distribution to the
public and the press.

## Summaries written by Georgia Commons

The following was written by claude-sonnet-5 from the text above and is not part of the resolution. Quote the text, not the summary.

A Georgia House resolution recognizes September 16, 2026, as National Ovarian Cancer Awareness Day at the state capitol, drawing attention to the disease's risks and detection challenges.

### Plain-language summary

This resolution from the Georgia House of Representatives designates September 16, 2026, as National Ovarian Cancer Awareness Day at the state capitol. It does not change any law or create any program. Instead, it lays out a long series of factual findings about ovarian cancer, including its mortality rate, survival statistics, racial disparities in diagnosis and outcomes, the lack of a reliable early detection test, common symptoms, and the role of genetic factors like BRCA gene mutations.
The resolution formally states that House members recognize the day, and it directs the Clerk of the House to prepare copies of the resolution for distribution to the public and press. It has no funding attached and does not require any state agency to take action beyond this recognition and distribution.

### What it does

- Formally designates September 16, 2026, as National Ovarian Cancer Awareness Day at the Georgia state capitol.
- Directs the Clerk of the House of Representatives to prepare and distribute copies of the resolution to the public and press.
- Creates no new law, funding, agency requirement, or penalty; it is a symbolic recognition rather than a binding policy change.

### Who it affects

The resolution primarily affects public awareness efforts around ovarian cancer in Georgia. It references women generally, and specifically Black women, low-income women, rural women, and women in the military, as groups facing higher risks or worse outcomes, though the resolution itself creates no obligations for any of these groups.

### Why it matters

While the resolution carries no legal force, it puts the Georgia House on record highlighting gaps in ovarian cancer detection, disparities in outcomes for Black women, and the value of genetic testing, which could support broader public awareness or advocacy efforts.

### Key provisions

- The resolving clause recognizes September 16, 2026, as National Ovarian Cancer Awareness Day at the state capitol.
- A further resolution directs the Clerk of the House to make copies available for distribution to the public and press.
- The whereas clauses cite statistics on survival rates, racial disparities, symptoms, and genetic risk factors like BRCA mutations, providing background rather than binding requirements.

## Status

- Status: Passed (2026-03-25)
- Last action: House Read and Adopted (2026-03-25)
- Sponsors: Lisa Campbell
- Official page: https://www.legis.ga.gov/legislation/74452

> The history, votes, and amendments (134 characters) are at https://georgiacommons.org/bills/2025-2026/hr1904.md?full=1